# Edesa Biotech, Inc. (EDSA)

> Healthcare · CA · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/EDSA/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 0 | $ -11.87M | $ -7.19M | $ 0 | $ 8.81M |
| 2025 | $ 0 | $ -7.36M | $ -7.59M | $ 0 | $ 12.45M |
| 2024 | $ 0 | $ -6.49M | $ -5.16M | $ 19.9K | $ 1.98M |
| 2023 | $ 0 | $ -9.05M | $ -7.22M | $ 94.5K | $ 7.05M |
| 2022 | $ 0 | $ -19.60M | $ -13.43M | $ 19.0K | $ 9.39M |
| 2021 | $ 0 | $ -15.86M | $ -16.25M | $ 99.3K | $ 13.06M |
| 2020 | $ 418.9K | $ -8.11M | $ -6.39M | $ 164.2K | $ 6.63M |
| 2019 | $ 750.8K | $ -6.85M | $ -7.96M | $ 0 | $ 5.26M |
| 2018 | $ 279.8K | $ -6.65M | $ -6.60M | $ 0 | $ 11.29M |
| 2017 | $ 307.5K | $ -6.78M | $ -6.74M | $ 0 | $ 7.40M |
| 2016 | $ 1.75M | $ -6.92M | $ -6.75M | $ 0 | $ 12.31M |
| 2015 | $ 1.07M | $ -3.99M | $ -6.58M | $ 0 | $ 8.01M |
| 2014 | $ 525.8K | $ -11.93M | $ -6.42M | $ 0 | $ 7.70M |
| 2013 | $ 775.8K | $ -21.17M | $ -4.17M | $ 0 | $ -3.14M |
| 2012 | $ 413.0K | $ -7.50M | $ -5.81M | $ 0 | $ 851.6K |
| 2011 | $ 1.02M | $ -10.41M | $ -4.30M | $ 0 | $ 4.59M |
| 2010 | $ 1.07M | $ -771.8K | $ -801.6K | $ 0 | $ 2.47M |
| 2009 | $ 0 | $ -62.9K | $ -16.1K | $ 0 | $ 323.9K |
| 2008 | $ 0 | $ -100.5K | N/A | N/A | N/A |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.00 |
| Liabilities / Eq | 0.44 |
| Current Ratio | 2.76 |

## Other views

- [Metrics](https://sponda.capital/en/EDSA.md)
- [Charts](https://sponda.capital/en/EDSA/charts.md)
- [Compare](https://sponda.capital/en/EDSA/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-29.